Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Sperm antibodies

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 89325 refers to the test for sperm antibodies, commonly known as the antisperm antibody test. This diagnostic procedure is essential in evaluating cases of infertility that may be attributed to an immune response against sperm. In this context, the immune system of either the male or female partner may produce antibodies that target and damage sperm, leading to a condition known as immunologic infertility. Sperm antibodies are specific proteins that can be found in various bodily fluids, including blood, vaginal secretions, and semen. These antibodies recognize sperm as foreign entities and mount an immune response against them. In men, the development of sperm antibodies can occur due to several factors, including infections, traumatic injuries, or surgical procedures involving the testicles, such as biopsies or vasectomies. Notably, a significant number of men who experience fertility issues after undergoing a vasectomy reversal may be diagnosed with immunologic infertility. On the other hand, women can also produce antibodies against their partner's sperm or semen, which can further complicate fertility. To detect the presence of these sperm-bound antibodies, an immunobead test (IBT) is utilized. This test typically assesses both IgA and IgG antibody classes, and it is important to note that CPT® Code 89325 is reported separately for each immunoglobulin class tested. This detailed approach allows for a comprehensive evaluation of potential immunologic factors contributing to infertility.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The sperm antibody test (CPT® Code 89325) is indicated in various clinical scenarios where infertility is suspected to be linked to an immune response against sperm. The following conditions may warrant the performance of this test:

  • Immunologic Infertility This condition arises when the immune system produces antibodies that attack sperm, leading to difficulties in conception.
  • Post-Vasectomy Reversal Fertility Issues Men who experience fertility problems after a successful vasectomy reversal may be evaluated for the presence of sperm antibodies.
  • History of Testicular Surgery Surgical procedures such as biopsies or vasectomies can lead to the development of sperm antibodies, necessitating testing.
  • Infections or Traumatic Injuries Men who have had infections or injuries affecting the testicles may also be at risk for developing sperm antibodies.
  • Female Partner's Immune Response Women who may have developed antibodies against their partner's sperm or semen can also be evaluated using this test.

2. Procedure

The procedure for testing sperm antibodies involves several key steps to ensure accurate results. The following outlines the procedural steps associated with CPT® Code 89325:

  • Step 1: Sample Collection A sample of blood, vaginal fluid, or semen is collected from the patient. The choice of sample type depends on the specific clinical scenario and the physician's discretion.
  • Step 2: Laboratory Analysis The collected sample is sent to a laboratory where it undergoes analysis to detect the presence of sperm-bound antibodies. This typically involves the use of an immunobead test (IBT), which is designed to identify antibodies that may be attached to sperm.
  • Step 3: Testing for Immunoglobulin Classes Both IgA and IgG antibody tests are performed to provide a comprehensive assessment of the immune response. Each immunoglobulin class is reported separately under CPT® Code 89325.
  • Step 4: Result Interpretation The laboratory results are interpreted by a qualified healthcare professional, who will assess the presence and levels of sperm antibodies to determine their potential impact on fertility.

3. Post-Procedure

After the sperm antibody test is completed, the patient may receive guidance based on the results. If sperm antibodies are detected, further evaluation and treatment options may be discussed with the healthcare provider. This could include potential interventions to address immunologic infertility or referrals to fertility specialists. It is important for patients to follow up with their healthcare provider to understand the implications of the test results and to explore appropriate next steps in their fertility journey.

Short Descr SPERM ANTIBODY TEST
Medium Descr SPERM ANTIBODIES
Long Descr Sperm antibodies
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
Date
Action
Notes
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"